Clinical Trials

New Search
Title   Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Disease/Condition   Lung Cancer,Lung Diseases,Carcinoma,Neoplasms
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Haiying Cheng, MD
Contact Name   Remy Lambert
Contact Email   rlambert@montefiore.org
IRB/Protocol Number   44-15-004
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   NSCLC post-surgical removal